# Beta Adrenergic Receptor Blockade as a Novel Therapy for Patients With Adenocarcinoma of the Prostate

> **NCT02944201** · PHASE2 · UNKNOWN · sponsor: **Montefiore Medical Center** · enrollment: 22 (estimated)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** Carvedilol

## Key facts

- **NCT ID:** NCT02944201
- **Lead sponsor:** Montefiore Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-04-01
- **Primary completion:** 2020-12-31
- **Final completion:** 2021-12-31
- **Target enrollment:** 22 (ESTIMATED)
- **Last updated:** 2021-02-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02944201

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02944201, "Beta Adrenergic Receptor Blockade as a Novel Therapy for Patients With Adenocarcinoma of the Prostate". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02944201. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*